Patents by Inventor Alexandre Cote

Alexandre Cote has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6677367
    Abstract: A compound selected from the group consisting of a compound of formula I a compound of formula II and when the compound of formula I and II comprises an amino group pharmaceutically acceptable ammonium salts thereof, wherein R1, R2, Cx, n, R3, R4, R5, Y are as defined in the specification.
    Type: Grant
    Filed: October 24, 2002
    Date of Patent: January 13, 2004
    Assignee: Pharmacor Inc.
    Inventors: Brent Richard Stranix, Gilles Sauvé, Abderrahim Bouzide, Alexandre Coté, Gervais Bérubé, Patrick Soucy, Yongsen Zhao, Jocelyn Yelle
  • Patent number: 6656965
    Abstract: A compound selected from the group consisting of a compound of formula I a compound of formula II and when the compound of formula I and II comprises an amino group pharmaceutically acceptable ammonium salts thereof, wherein R1, R2, Cx, n, R3, R4, R5, Y are as defined in the specification.
    Type: Grant
    Filed: September 17, 2002
    Date of Patent: December 2, 2003
    Assignee: Pharmacor Inc.
    Inventors: Brent Richard Stranix, Gilles Sauvé, Abderrahim Bouzide, Alexandre Coté, Gervais Bérubé, Patrick Soucy, Yongsen Zhao, Jocelyn Yelle
  • Publication number: 20030195159
    Abstract: A compound selected from the group consisting of a compound of formula I 1
    Type: Application
    Filed: October 24, 2002
    Publication date: October 16, 2003
    Inventors: Brent Richard Stranix, Gilles Sauve, Abderrahim Bouzide, Alexandre Cote, Gervais Berube, Patrick Soucy, Yongsen Zhao, Jocelyn Yelle
  • Patent number: 6610689
    Abstract: A compound selected from the group consisting of a compound of formula I a compound of formula II and when the compound of formula I and II comprises an amino group pharmaceutically acceptable ammonium salts thereof, wherein R1, R2, Cx, n, R3, R4, R5, Y are as defined in the specification.
    Type: Grant
    Filed: September 17, 2002
    Date of Patent: August 26, 2003
    Assignee: Pharmacor Inc.
    Inventors: Brent Richard Stranix, Gilles Sauvé, Abderrahim Bouzide, Alexandre Coté, Gervais Bérubé, Patrick Soucy, Yongsen Zhao, Jocelyn Yelle
  • Patent number: 6608100
    Abstract: A compound selected from the group consisting of a compound of formula I a compound of formula II and when the compound of formula I and II comprises an amino group pharmaceutically acceptable ammonium salts thereof, wherein R1, R2, Cx, n, R3, R4, R5, Y are as defined in the specification.
    Type: Grant
    Filed: September 17, 2002
    Date of Patent: August 19, 2003
    Assignee: Pharmacor Inc.
    Inventors: Brent Richard Stranix, Gilles Sauvé, Abderrahim Bouzide, Alexandre Coté, Gervais Bérubé, Patrick Soucy, Yongsen Zhao, Jocelyn Yelle
  • Publication number: 20030144265
    Abstract: A compound selected from the group consisting of a compound of formula I 1
    Type: Application
    Filed: September 17, 2002
    Publication date: July 31, 2003
    Inventors: Brent Richard Stranix, Gilles Sauve, Abderrahim Bouzide, Alexandre Cote, Gervais Berube, Patrick Soucy, Yongsen Zhao, Jocelyn Yelle
  • Publication number: 20030119803
    Abstract: A compound selected from the group consisting of a compound of formula I 1
    Type: Application
    Filed: September 17, 2002
    Publication date: June 26, 2003
    Inventors: Brent Richard Stranix, Gilles Sauve, Abderrahim Bouzide, Alexandre Cote, Gervais Berube, Patrick Soucy, Yongsen Zhao, Jocelyn Yelle
  • Patent number: 6506786
    Abstract: A compound selected from the group consisting of a compound of formula I a compound of formula II and when the compound of formula I and II comprises an amino group pharmaceutically acceptable ammonium salts thereof, wherein R1, R2, Cx, n, R3, R4, R5, Y are as defined in the specification.
    Type: Grant
    Filed: February 13, 2001
    Date of Patent: January 14, 2003
    Assignee: Pharmacor Inc.
    Inventors: Brent Richard Stranix, Gilles Sauvé, Abderrahim Bouzide, Alexandre Coté, Gervais Bérubé, Patrick Soucy, Yongsen Zhao, Jocelyn Yelle
  • Publication number: 20020151546
    Abstract: A compound selected from the group consisting of a compound of formula I 1
    Type: Application
    Filed: February 13, 2001
    Publication date: October 17, 2002
    Inventors: Brent Richard Stranix, Gilles Sauve, Abderrahim Bouzide, Alexandre Cote, Gervais Berube, Patrick Soucy, Yongsen Zhao, Jocelyn Yelle